(S1 (S (S (NP (NP (NN NF-kappaB) (NN inhibition)) (PP (IN by) (NP (NN PMA)))) (VP (VBD correlated) (PP (TO to) (NP (JJ PKC-dependent) (NN Bcl10) (NN degradation))))) (. .)))
(S1 (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (JJ intracellular) (NN protein)))) (VP (VBD were) (VP (VBN assessed) (PP (VBG following) (NP (NP (ADJP (CD 24) (NN h)) (NN stimulation)) (PP (IN with) (NP (NP (NP (NN PMA)) (PRN (-LRB- -LRB-) (NP (CD 162) (NN nM)) (-RRB- -RRB-))) (CC or) (NP (NP (NN HK) (FW E.) (FW coli)) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (CC x) (CD 107)) (NN CFU/ml)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Phospho-PKC)) (VP (VBD increased) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (NN PMA)) (CC and) (NP (NN HK)) (NP (FW E.) (FW coli))) (NN stimulation))))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN IkappaB)) (VP (VBD decreased) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN HK))) (ADJP (FW E.) (FW coli)))) (S (VP (VBG indicating) (NP (NN NF-kappaB) (NN activation)))))) (. .)))
(S1 (S (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NN Bcl10) (NN activation)) (VP (VBD was) (VP (VBN inhibited) (PP (VBG following) (NP (NP (JJ long-term) (NN stimulation)) (PP (IN with) (NP (NN PMA))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ explains) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN PMA))) (PP (IN on) (NP (NN NF-kappaB)))))))))))) (CC activation.) (S (NP (NN beta-actin)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN loading) (NN control))))))) (. .)))
(S1 (S (S (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 3)) (-RRB- -RRB-))) (. .)))
